Answers are grounded in this paper and cite their sources.
Retrospective cohort study assessed total serum immunoglobulin M's utility for congenital infections in infants, suggesting low diagnostic yield.
Diagnosing congenital infections (CIs) poses challenges due to diverse clinical presentations. Total serum immunoglobulin M (IgM) has been used as a screening tool for CIs, but its efficacy remains uncertain. In this single-center retrospective cohort study conducted between April 2018 and April 2022 at a level III Neonatal Intensive Care Unit (NICU), we aimed to review the literature on and assess the utility of total serum IgM in diagnosing CIs in newborns. Among 53 infants with total serum IgM measurements, only one value was modestly elevated. Further testing for congenital pathogens was negative. The most frequently cited reason for obtaining total serum IgM was isolated small for gestational age (SGA) status; however, alternative explanations for SGA status were present in most cases. Considering no CIs were diagnosed in our cohort, and > 98% of total serum IgM values were normal, we conclude screening infants with isolated abnormalities is of low yield. If testing is pursued, targeted testing is recommended over broad screening.
No takes yet. Share an insight, caveat, or question.
Joslyn et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: